Search results
Hindenburg claims it hardly made money by shorting Adani stocks and bonds: ‘Reality is…’
Hindustan Times· 2 days agoThe admission came in response to a show cause notice issued by markets regulator Sebi to Hindenburg...
Earnings growth likely to be in mid-teens; overall growth trajectory remains strong: Shibani Sircar...
The Economic Times· 3 days agoOn this base, for FY25 and FY26, a mid-teens earnings growth expectation is still strong given the...
Potential for huge NRI money coming into India via GIFT city: Bhavin Shah
The Economic Times· 3 days agoA lot of NRIs are going to their advisors and asking them for choices to invest in India and they...
Spend on the world like never before - The Economic Times
The Economic Times· 3 days agoIndians are travelling abroad in significant numbers, soaking up a large part of dollars that migrant workers send back home to their relatives. Travel ...
Draining the Swamp - The Shillong Times
Shillong Times· 3 days agoThe title of this article is inspired by a 1996 book written by Harvey Francis Barnard, ‘Draining the Swamp – Monetary & Fiscal Policy Reform.’ To put it...
Hydropower Remains Renewable Leader Despite Climate Challenges
POWER Magazine· 3 days agoAs the oldest renewable energy resource, hydropower is well-established as a reliable source of...
Tata Elxsi’s Dark NOC Could Save Millions for Network Operators
Analytics India Magazine· 3 days agoTransitioning from 4G to 5G could cost network operators millions of dollars. Tata Elxsi has found a...
We need better information on the impact of climate change
Livemint· 3 days agoAnd yet economists—clearly able to keep cool heads when everybody else is losing theirs—are in the...
French shares up 2.8% as far right party takes lead in first round of election
CNBC Awaaz· 3 days agoShares advanced early Monday in Europe, with the benchmark in Paris up 2.8% after the far-right National Rally gained a strong lead & ...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 3 days agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...